Bisphosphonate-loaded PLGA microspheres for bone regeneration in dental surgery: formulation, characterization, stability, and comprehensive release kinetic studies

References

• Haynes, D. R.; Crotti, T. N.; Zreiqat, H. Regulation of Osteoclast Activity in Peri-Implant Tissues. Biomaterials 2004, 25, 4877–4885. DOI: 10.1016/j.biomaterials.2004.01.003.
   PubMed Web of Science ®Google Scholar
• Zhang, C.; Zhang, T.; Geng, T.; Wang, X.; Lin, K.; Wang, P. Dental Implants Loaded with Bioactive Agents Promote Osseointegration in Osteoporosis: A Review. Front. Bioeng. Biotechnol. 2021, 9, 591796. DOI: 10.3389/fbioe.2021.591796.
   PubMed Web of Science ®Google Scholar
• Retzepi, M.; Donos, N. Guided Bone Regeneration: Biological Principle and Therapeutic Applications. Clin. Oral Implants Res. 2010, 21, 567–576. DOI: 10.1111/j.1600-0501.2010.01922.x.
   PubMed Web of Science ®Google Scholar
• Brown, J. E.; Coleman, R. E. The Present and Future Role of Bisphosphonates in the Management of Patients with Breast Cancer. Breast Cancer Res. 2002, 4, 24–29. DOI: 10.1186/bcr413.
   PubMed Web of Science ®Google Scholar
• von Knoch, F.; Jaquiery, C.; Kowalsky, M.; Schaeren, S.; Alabre, C.; Martin, I.; Rubash, H. E.; Shanbhag, A. S. Effects of Bisphosphonates on Proliferation and Osteoblast Differentiation of Human Bone Marrow Stromal Cells. Biomaterials 2005, 26, 6941–6949. DOI: 10.1016/j.biomaterials.2005.04.059.
   PubMed Web of Science ®Google Scholar
• Reinholz, G. G.; Getz, B.; Pederson, L.; Sanders, E. S.; Subramaniam, M.; Ingle, J. N.; Spelsberg, T. C. Bisphosphonates Directly Regulate Cell Proliferation, Differentiation, and Gene Expression in Human Osteoblasts. Cancer Res. 2000, 60, 6001–6007. DOI: 10.1054/bjoc.2001.1679.
   PubMed Web of Science ®Google Scholar
• Miladi, K.; Sfar, S.; Fessi, H.; Elaissari, A. Encapsulation of Alendronate Sodium by Nanoprecipitation and Double Emulsion: From Preparation to in Vitro Studies. Ind. Crops Prod. 2015, 72, 24–33. DOI: 10.1016/j.indcrop.2015.01.079.
   Web of Science ®Google Scholar
• Carvalho Dutra, B.; Oliveira, A.; Oliveira, P. A. D.; Miranda Cota, L. O.; Silveira, J. O.; Costa, F. O. Effects of Topical Application of 1% Sodium Alendronate Gel in the Surgical Treatment of Periodontal Intrabony Defects: A 6-Month Randomized Controlled Clinical Trial. J. Periodontol. 2019, 90, 1079–1087. DOI: 10.1002/JPER.19-0160.
   PubMed Web of Science ®Google Scholar
• Bone, H. G.; Hosking, D.; Devogelaer, J. P.; Tucci, J. R.; Emkey, R. D.; Tonino, R. P.; Rodriguez-Portales, J. A.; Downs, R. W.; Gupta, J.; Santora, A. C.; et al. Ten Years’ Experience with Alendronate for Osteoporosis in Postmenopausal Women. N. Engl. J. Med. 2004, 350, 1189–1199. DOI: 10.1056/NEJMoa030897.
   PubMed Web of Science ®Google Scholar
• Russell, R.; Watts, N.; Ebetino, F.; Rogers, M. Mechanisms of Action of Bisphosphonates: similarities and Differences and Their Potential Influence on Clinical Efficacy. Osteoporos Int. 2008, 19, 733–759. DOI: 10.1007/s00198-007-0540-8.
   PubMed Web of Science ®Google Scholar
• Öz, U. C.; Toptaş, M.; Küçüktürkmen, B.; Devrim, B.; Saka, O. M.; Deveci, M. S.; Bilgili, H.; Ünsal, E.; Bozkır, A. Guided Bone Regeneration by the Development of Alendronate Sodium Loaded in-Situ Gel and Membrane Formulations. Eur. J. Pharm. Sci. 2020, 155, 105561. DOI: 10.1016/j.ejps.2020.105561.
   PubMed Web of Science ®Google Scholar
• Chacon, G. E.; Stine, E. A.; Larsen, P. E.; Beck, F. M.; McGlumphy, E. A. Effect of Alendronate on Endosseous Implant Integration: An In Vivo Study in Rabbits. J. Oral. Maxillofac. Surg. 2006, 64, 1005–1009. DOI: 10.1016/j.joms.2006.01.007.
   PubMed Web of Science ®Google Scholar
• Wysowski, D. K.; Chang, J. T. Alendronate and Risedronate: Reports of Severe Bone, Joint, and Muscle Pain. Arch. Intern. Med. 2005, 165, 346–347. DOI: 10.1001/archinte.165.3.346-b.
   PubMedGoogle Scholar
• Penning-van Beest, F. J.; Goettsch, W. G.; Erkens, J. A.; Herings, R. M. Determinants of Persistence with Bisphosphonates: A Study in Women with Postmenopausal Osteoporosis. Clin. Ther. 2006, 28, 236–242. DOI: 10.1016/j.clinthera.2006.01.002.
   PubMed Web of Science ®Google Scholar
• Ideguchi, H.; Ohno, S.; Hattori, H.; Ishigatsubo, Y. Persistence with Bisphosphonate Therapy Including Treatment Courses with Multiple Sequential Bisphosphonates in the Real World. Osteoporos Int. 2007, 18, 1421–1427. DOI: 10.1007/s00198-007-0406-0.
   PubMed Web of Science ®Google Scholar
• Yaffe, A.; Fine, N.; Alt, I.; Binderman, I. The Effect of Bisphosphonate on Alveolar Bone Resorption following Mucoperiosteal Flap Surgery in the Mandible of Rats. J. Periodontol. 1995, 66, 999–1003. DOI: 10.1902/jop.1995.66.11.999.
   PubMed Web of Science ®Google Scholar
• Yaffe, A.; Iztkovich, M.; Earon, Y.; Alt, I.; Lilov, R.; Binderman, I. Local Delivery of an Amino Bisphosphonate Prevents the Resorptive Phase of Alveolar Bone following Mucoperiosteal Flap Surgery in Rats. J. Periodontol. 1997, 68, 884–889. DOI: 10.1902/jop.1997.68.9.884.
   PubMed Web of Science ®Google Scholar
• Meraw, S. J.; Reeve, C. M.; Wollan, P. C. Use of Alendronate in Peri‐Implant Defect Regeneration. J. Periodontol. 1999, 70, 151–158. DOI: 10.1902/jop.1999.70.2.151.
   PubMed Web of Science ®Google Scholar
• Binderman, I.; Adut, M.; Yaffe, A. Effectiveness of Local Delivery of Alendronate in Reducing Alveolar Bone Loss following Periodontal Surgery in Rats. J. Periodontol. 2000, 71, 1236–1240. DOI: 10.1902/jop.2000.71.8.1236.
   PubMed Web of Science ®Google Scholar
• Yoshinari, M.; Oda, Y.; Inoue, T.; Matsuzaka, K.; Shimono, M. Bone Response to Calcium Phosphate-Coated and Bisphosphonate-Immobilized Titanium Implants. Biomaterials 2002, 23, 2879–2885. DOI: 10.1016/S0142-9612(01)00415-X.
   PubMed Web of Science ®Google Scholar
• Danhier, F.; Ansorena, E.; Silva, J. M.; Coco, R.; Le Breton, A.; Preat, V. PLGA-Based Nanoparticles: An Overview of Biomedical Applications. J. Control. Release 2012, 161, 505–522. DOI: 10.1016/j.jconrel.2012.01.043.
   PubMed Web of Science ®Google Scholar
• Martins, C.; Sousa, F.; Araujo, F.; Sarmento, B. Functionalizing PLGA and PLGA Derivatives for Drug Delivery and Tissue Regeneration Applications. Adv. Healthcare Mater. 2018, 7, 1701035. DOI: 10.1002/adhm.201701035.
   Web of Science ®Google Scholar
• Pardeshi, S. R.; Nikam, A.; Chandak, P.; Mandale, V.; Naik, J. B.; Giram, P. S. Recent Advances in PLGA Based Nanocarriers for Drug Delivery System: A State of the Art Review. Int. J. Polym. Mater. Polym. Biomat. 2021, 1–30. DOI: 10.1080/00914037.2021.1985495.
   Web of Science ®Google Scholar
• Ruhe, P.; Boerman, O.; Russel, F.; Spauwen, P.; Mikos, A.; Jansen, J. Controlled Release of rhBMP-2 Loaded Poly (dl-Lactic-co-Glycolic Acid)/Calcium Phosphate Cement Composites in Vivo. J. Control. Release 2005, 106, 162–171. DOI: 10.1016/j.jconrel.2005.04.018.
   PubMed Web of Science ®Google Scholar
• Marin, E.; Briceño, M. I.; Caballero-George, C. Critical Evaluation of Biodegradable Polymers Used in Nanodrugs. Int. J. Nanomed. 2013, 8, 3071–3090. DOI: 10.2147/IJN.S47186.
   PubMed Web of Science ®Google Scholar
• Virlan, M. J. R.; Miricescu, D.; Totan, A.; Greabu, M.; Tanase, C.; Sabliov, C. M.; Caruntu, C.; Calenic, B. Current Uses of Poly (Lactic-co-Glycolic Acid) in the Dental Field: A Comprehensive Review. J. Chem. 2015, 2015, 1–12. DOI: 10.1155/2015/525832.
   Web of Science ®Google Scholar
• Elmsmari, F.; González Sánchez, J. A.; Duran‐Sindreu, F.; Belkadi, R.; Espina, M.; García, M. L.; Sánchez‐López, E. Calcium Hydroxide-Loaded PLGA Biodegradable Nanoparticles as an Intracanal Medicament . Int. Endod. J. 2021, 54, 2086–2098. DOI: 10.1111/iej.13603.
   PubMed Web of Science ®Google Scholar
• Yoshimoto, I.; Sasaki, J.-I.; Tsuboi, R.; Yamaguchi, S.; Kitagawa, H.; Imazato, S. Development of Layered PLGA Membranes for Periodontal Tissue Regeneration. Dent. Mater. 2018, 34, 538–550. DOI: 10.1016/j.dental.2017.12.011.
   PubMed Web of Science ®Google Scholar
• Nafea, E. H.; El-Massik, M. A.; El-Khordagui, L. K.; Marei, M. K.; Khalafallah, N. M. Alendronate PLGA Microspheres with High Loading Efficiency for Dental Applications. J. Microencapsul. 2007, 24, 525–538. DOI: 10.1080/02652040701439807.
   PubMed Web of Science ®Google Scholar
• Ostović, D.; Stelmach, C.; Hulshizer, B. Formation of a Chromophoric Complex between Alendronate and Copper (II) Ions. Pharm. Res. 1993, 10, 470–472. DOI: 10.1023/A:1018969112754.
   PubMed Web of Science ®Google Scholar
• Perugini, P.; Genta, I.; Conti, B.; Modena, T.; Pavanetto, F. Long-Term Release of Clodronate from Biodegradable Microspheres. AAPS PharmSciTech 2001, 2, E10. DOI: 10.1208/pt020310.
   PubMedGoogle Scholar
• Virto, M. R.; Elorza, B.; Torrado, S.; Elorza, M.; Frutos, G. Improvement of Gentamicin Poly (D, L-Lactic-co-Glycolic Acid) Microspheres for Treatment of Osteomyelitis Induced by Orthopedic Procedures. Biomaterials 2007, 28, 877–885. DOI: 10.1016/j.biomaterials.2006.09.045.
   PubMed Web of Science ®Google Scholar
• Guideline, I. H. T. Validation of Analytical Procedures: text and Methodology. Q2 (R1) 2005, 1, 05.
   Google Scholar
• D'Souza, S. S.; DeLuca, P. P. Methods to Assess in Vitro Drug Release from Injectable Polymeric Particulate Systems. Pharm. Res. 2006, 23, 460–474. DOI: 10.1007/s11095-005-9397-8.
   PubMed Web of Science ®Google Scholar
• Samdancioglu, S.; Calis, S.; Sumnu, M.; Atilla Hincal, A. Formulation and in Vitro Evaluation of Bisphosphonate Loaded Microspheres for Implantation in Osteolysis. Drug. Dev. Ind. Pharm. 2006, 32, 473–481. DOI: 10.1080/03639040500528871.
   PubMed Web of Science ®Google Scholar
• Guideline, I. Stability Testing of New Drug Substances and Products. Q1A (R2) Curr. Step 2003, 4, 1–24.
   Google Scholar
• U.S. Food and Drug Administration. Guidance for Industry: Dissolution Testing of Immediate-Release Solid Oral Dosage Forms. Center for Drug Evaluation and Research (CDER), USA, 1997; pp 1–11.
   Google Scholar
• Aldeek, F.; McCutcheon, N.; Smith, C.; Miller, J. H.; Danielson, T. L. Dissolution Testing of Nicotine Release from OTDN Pouches: Product Characterization and Product-to-Product Comparison. Separations 2021, 8, 7. DOI: 10.3390/separations8010007.
   Web of Science ®Google Scholar
• Puthli, S.; Vavia, P. R. Stability Studies of Microparticulate System with Piroxicam as Model Drug. AAPS PharmSciTech 2009, 10, 872–880. DOI: 10.1208/s12249-009-9280-8.
   PubMed Web of Science ®Google Scholar
• Zhang, Y.; Huo, M.; Zhou, J.; Zou, A.; Li, W.; Yao, C.; Xie, S. DDSolver: An Add-in Program for Modeling and Comparison of Drug Dissolution Profiles. AAPS J. 2010, 12, 263–271. DOI: 10.1208/s12248-010-9185-1.
   PubMed Web of Science ®Google Scholar
• Murtaza, G.; Ahmad, M.; Khan, S. A.; Hussain, I. Evaluation of Cefixime-Loaded Chitosan Microspheres: Analysis of Dissolution Data Using DDSolver. Dissolution Technol. 2012, 19, 13–19. DOI: 10.14227/DT190212P13.
   Web of Science ®Google Scholar
• Jain, R. A. The Manufacturing Techniques of Various Drug Loaded Biodegradable Poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000, 21, 2475–2490. DOI: 10.1016/S0142-9612(00)00115-0.
   PubMed Web of Science ®Google Scholar
• Siepmann, J.; Faisant, N.; Benoit, J.-P. A New Mathematical Model Quantifying Drug Release from Bioerodible Microparticles Using Monte Carlo Simulations. Pharm. Res. 2002, 19, 1885–1893. DOI: 10.1023/A:1021457911533.
   PubMed Web of Science ®Google Scholar
• Yasukawa, T.; Kimura, H.; Tabata, Y.; Ogura, Y. Biodegradable Scleral Plugs for Vitreoretinal Drug Delivery. Adv. Drug Deliv. Rev. 2001, 52, 25–36. DOI: 10.1016/S0169-409X(01)00192-2.
   PubMed Web of Science ®Google Scholar
• Chen, X.; Ooi, C. P.; Lim, T. H. Effect of Ganciclovir on the Hydrolytic Degradation of Poly(Lactide-co-Glycolide) Microspheres. J. Biomater. Appl. 2006, 20, 287–302. DOI: 10.1177/0885328206054265.
   PubMed Web of Science ®Google Scholar
• Sayin, B.; Calis, S. Influence of Accelerated Storage Conditions on the Stability of Vancomycin-Loaded Poly (d, l-Lactide-co-Glycolide) Microspheres. FABAD J. Pharm. Sci. 2004, 29, 111–116.
   Google Scholar
• Andhariya, J. V.; Shen, J.; Wang, Y.; Choi, S.; Burgess, D. J. Effect of Minor Manufacturing Changes on Stability of Compositionally Equivalent PLGA Microspheres. Int. J. Pharm. 2019, 566, 532–540. DOI: 10.1016/j.ijpharm.2019.06.014.
   PubMed Web of Science ®Google Scholar
• Holzer, M.; Vogel, V.; Mantele, W.; Schwartz, D.; Haase, W.; Langer, K. Physico-Chemical Characterisation of PLGA Nanoparticles after Freeze-Drying and Storage. Eur. J. Pharm. Biopharm. 2009, 72, 428–437. DOI: 10.1016/j.ejpb.2009.02.002.
   PubMed Web of Science ®Google Scholar
• Yang, H.; Li, J.; Patel, S. K.; Palmer, K. E.; Devlin, B.; Rohan, L. C. Design of Poly (Lactic-co-Glycolic Acid)(PLGA) Nanoparticles for Vaginal Co-delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV Prophylaxis. Pharmaceutics 2019, 11, 184. DOI: 10.3390/pharmaceutics11040184.
   PubMed Web of Science ®Google Scholar
• Papadopoulou, V.; Kosmidis, K.; Vlachou, M.; Macheras, P. On the Use of the Weibull Function for the Discernment of Drug Release Mechanisms. Int. J. Pharm. 2006, 309, 44–50. DOI: 10.1016/j.ijpharm.2005.10.044.
   PubMed Web of Science ®Google Scholar
• Sorasitthiyanukarn, F. N.; Muangnoi, C.; Bhuket, P. R. N.; Rojsitthisak, P.; Rojsitthisak, P. Chitosan/Alginate Nanoparticles as a Promising Approach for Oral Delivery of Curcumin Diglutaric Acid for Cancer Treatment. Mater. Sci. Eng. C Mater. Biol. Appl. 2018, 93, 178–190. DOI: 10.1016/j.msec.2018.07.069.
   PubMed Web of Science ®Google Scholar
• Sanchez, L. T.; Pinzon, M. I.; Villa, C. C. Development of Active Edible Films Made from Banana Starch and Curcumin-Loaded Nanoemulsions. Food Chem. 2022, 371, 131121. DOI: 10.1016/j.foodchem.2021.131121.
   PubMed Web of Science ®Google Scholar
• Ainurofiq, A.; Choiri, S. Drug Release Mechanism of Slightly Soluble Drug from Nanocomposite Matrix Formulated with Zeolite/Hydrotalcite as Drug Carrier. Trop. J. Pharm. Res. 2015, 14, 1129–1135. DOI: 10.4314/tjpr.v14i7.2.
   Web of Science ®Google Scholar
• Puga, A. M.; Rey-Rico, A.; Magarinos, B.; Alvarez-Lorenzo, C.; Concheiro, A. Hot Melt Poly-Epsilon-Caprolactone/Poloxamine Implantable Matrices for Sustained Delivery of Ciprofloxacin. Acta Biomater. 2012, 8, 1507–1518. DOI: 10.1016/j.actbio.2011.12.020.
   PubMed Web of Science ®Google Scholar
• Sanna, V.; Roggio, A. M.; Pala, N.; Marceddu, S.; Lubinu, G.; Mariani, A.; Sechi, M. Effect of Chitosan Concentration on PLGA Microcapsules for Controlled Release and Stability of Resveratrol. Int. J. Biol. Macromol. 2015, 72, 531–536. DOI: 10.1016/j.ijbiomac.2014.08.053.
   PubMed Web of Science ®Google Scholar